Literature DB >> 25185993

Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis.

Wei Liu1, Fang Tian, Liping Dai, Yurong Chai.   

Abstract

The gene polymorphism of Cytochrome P450 2E1 (CYP2E1) is supposed to be associated with cancer susceptibility. Many studies focusing on the Pst I/Rsa I polymorphism of CYP2E1 gene and hepatocellular carcinoma (HCC) risk have been conducted and the results are conflicting. In the current study, a meta-analysis of published studies was performed to assess the association between CYP2E1 Pst I/Rsa I polymorphism and risk to HCC. 11 studies containing 1,178 cases and 1,623 controls were selected to determine whether c2 allele of CYP2E1 gene can increase HCC susceptibility, especially through interacting with alcohol drinking. Using the random effects model, the result indicated that there was no association between CYP2E1 Pst I/Rsa I genotype and HCC risk [odds ratio (OR) 1.03 (95% confidence interval (CI): 0.76-1.40) for c2 variant allele and OR 0.82 (95% CI: 0.51-1.31) for c2 homozygotes compared with wild-type homozygotes]. The association between CYP2E1 (c2) variant allele and HCC susceptibility were found when interacting with alcohol [OR 2.88 (95% CI: 1.25-6.60)]. In conclusion, this meta-analysis results showed that Pst I/Rsa I polymorphism of CYP2E1may slightly increase the risk of HCC and alcohol consumption increases the probability of developing HCC, especially for the carriers of some CYP2E1 alleles. CYP2E1 Pst I/Rsa I polymorphism may contribute to the proportion cases of HCC, which needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25185993     DOI: 10.1007/s11033-014-3655-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

1.  Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.

Authors:  Chun-Xia Yang; Keitaro Matsuo; Zhi-Ming Wang; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

2.  CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.

Authors:  Stefania Boccia; Angelo De Lauretis; Francesco Gianfagna; Cornelia M van Duijn; Gualtiero Ricciardi
Journal:  Carcinogenesis       Date:  2006-07-11       Impact factor: 4.944

Review 3.  Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.

Authors:  Edyta Reszka; Wojciech Wasowicz; Jolanta Gromadzinska
Journal:  Br J Nutr       Date:  2006-10       Impact factor: 3.718

4.  [Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma].

Authors:  Xinping Ye; Tao Peng; Tangwei Liu; Zhixiong Su; Kaiyin Xiao; Liming Shang; Ming Su; Lequn Li
Journal:  Wei Sheng Yan Jiu       Date:  2010-01

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 6.  The changing pattern of epidemiology in hepatocellular carcinoma.

Authors:  Helena Nordenstedt; Donna L White; Hashem B El-Serag
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

7.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

9.  CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Authors:  Laura Silvestri; Laura Sonzogni; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Michela Leveri; Agostino Cividini; Mario U Mondelli; Emilio Civardi; Enrico M Silini
Journal:  Int J Cancer       Date:  2003-04-10       Impact factor: 7.396

Review 10.  Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Yadong Wang; Haiyan Yang; Li Li; Haiyu Wang; Congke Zhang; Gongju Yin; Baoyu Zhu
Journal:  Eur J Cancer       Date:  2009-12-22       Impact factor: 9.162

View more
  3 in total

1.  Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.

Authors:  Chun Wang; Jianping Gong; Hao Wu
Journal:  Biomed Rep       Date:  2017-06-14

Review 2.  Alcohol and Cancer: Mechanisms and Therapies.

Authors:  Anuradha Ratna; Pranoti Mandrekar
Journal:  Biomolecules       Date:  2017-08-14

3.  Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

Authors:  Yufeng Sun; Wenchao Li; Shiqi Shen; Xuejing Yang; Bing Lu; Xiaojing Zhang; Peng Lu; Yi Shen; Juling Ji
Journal:  J Transl Med       Date:  2019-11-26       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.